POP Surgeries Not Tied to Decreased Sexual Functioning
The researchers determined that there is “moderate to high quality data” supporting the influence of POP on sexual activity and function. Medscape Medical News …read more
The researchers determined that there is “moderate to high quality data” supporting the influence of POP on sexual activity and function. Medscape Medical News …read more
The company cited new data from the NIH showing no significant benefit for bamlanivimab in combination with remdesivir for people hospitalized with COVID-19. Medscape Medical News …read more
IHME researchers predict the potential number of lives saved from COVID-19 this winter based on different percentages of Americans following mask and social distancing recommendations. Medscape Medical News …read more
In a peer-reviewed observational study of 79,505 premenopausal women, researchers sought to determine whether a life-long history of irregular or long menstrual cycles was associated with premature death. Medscape Medical News …read more
“I think when we’re comparing these two drugs overall, we have a clear benefit/risk, and we need to take both of these potential toxicities seriously,” said a pharmacology researcher at ID Week2020. Medscape Medical News …read more
More than a third of male infertility visits were with providers other than urologists, one study found, but telehealth options have become a feasible alternative to expand access. Medscape Medical News …read more
In a campaign speech, Trump sought to cast some of the blame for the high reported US COVID death rates on physicians and hospitals, suggesting they profit from treating COVID patients. Medscape Medical News …read more
Only 31% had received the shot, despite clear evidence it is safe in all trimesters of pregnancy and benefits both mother and baby. Medscape Medical News …read more
Signs and symptoms of moderate to severe atopic dermatitis were significantly reduced with baricitinib 4 mg on top of topical corticosteroids, compared with placebo in the phase 3, BREEZE-AD7 study. Medscape Medical News …read more
Women treated with a TNF inhibitor were 81% less likely than men to have a 40% or greater improvement on Assessment of Spondyloarthritis International Society (ASAS) response criteria by 1 year. Medscape Medical News …read more